Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X). (Q37193446)
Jump to navigation
Jump to search
scientific article published on 22 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X). |
scientific article published on 22 May 2013 |
Statements
1 reference
Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X). (English)
1 reference
Julio Rosenstock
1 reference
John E Gerich
1 reference
Denis Raccah
1 reference
László Korányi
1 reference
Laura Maffei
1 reference
Gabor Boka
1 reference
Patrick Miossec
1 reference
1 reference
1 reference
Identifiers
1 reference